Abstract:Annals of Pharmacotherapy, Ahead of Print. Objective:This review focuses on evaluating literature for the use of inhaled mucolytics (hypertonic saline, mannitol, and dornase alfa), inhaled antibiotics (tobramycin, aztreonam, colistin, and amikacin), and inhaled corticosteroids in pediatric noncystic fibrosis bronchiectasis.Data Sources:A literature search via PubMed was conducted using the search terms "non-cystic fibrosis bronchiectasis," "primary ciliary dyskinesia," and "bronchiectasis" in combination with each inhaled agent of interest.Study Selection and Data Extraction:Studies were included if they were specific to patients with a clinical diagnosis of noncystic fibrosis bronchiectasis published from 1998 to July 2024.Data Synthesis:Several inhaled medications can be considered as maintenance therapies for pediatric patients with noncystic fibrosis bronchiectasis. Hypertonic saline could be considered for its potential airway clearance benefits and low risk of causing harm. Inhaled antipseudomonal antibiotics should be considered in patients who are colonized with Pseudomonas aeruginosa. Inhaled corticosteroid therapy should be reserved for patients with concomitant asthma. Dornase alfa has shown worse outcomes in adults with noncystic fibrosis bronchiectasis and should be used with caution. Risks and benefits should be carefully considered when evaluating these therapies for use in noncystic fibrosis bronchiectasis, and patient-specific treatment regimens should be developed.Relevance to Patient Care and Clinical Practice:Chronic management of pediatric noncystic fibrosis bronchiectasis remains challenging due to paucity of applicable literature. Risks and benefits of different agents are discussed in this article with recommendations for application to clinical practice based on studies performed in both adult and pediatric patients with noncystic fibrosis bronchiectasis.Conclusion:Several inhaled medications could be considered as maintenance therapies for pediatric patients with noncystic fibrosis bronchiectasis, with more robust evidence to support use of inhaled antipseudomonal antibiotics and hypertonic saline compared with other available agents. Further investigation is needed to identify a clear place in therapy for inhaled therapies in pediatric noncystic fibrosis bronchiectasis.

The Role of Nebulized Antibiotics in Treating Serious Respiratory Infections

How to Use Nebulized Antibiotics in Severe Respiratory Infections

Inhaled Antibiotic Therapy in Chronic Respiratory Diseases

A research pathway for the study of the delivery and disposition of nebulised antibiotics: an incremental approach from in vitro to large animal models

Understanding the nebulisation of antibiotics: the key role of lung microdialysis studies

Comment on "Strangeness -2 hypertriton".

Current and Emerging Inhaled Antibiotics for Chronic Pulmonary Pseudomonas aeruginosa and Staphylococcus aureus Infections in Cystic Fibrosis

Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives

Use of mucolytics and inhaled antibiotics in the NICU

Inhaled antibiotics: A promising drug delivery strategies for efficient treatment of lower respiratory tract infections (LRTIs) associated with antibiotic resistant biofilm-dwelling and intracellular bacterial pathogens

Aspects of pulmonary drug delivery strategies for infections in cystic fibrosis – where do we stand?

Nebulization of Antimicrobial Agents in Mechanically Ventilated Adults in 2017: an International Cross-Sectional Survey

The Unfulfilled Promise of Inhaled Therapy in Ventilator-Associated Infections: Where Do We Go from Here?

Inhaled Medications for Maintenance Therapy in Pediatric Noncystic Fibrosis Bronchiectasis

Antibiotic loaded inhalable liposomal nanoparticles against lower respiratory tract infections: Challenges, recent advances, and future perspectives

Antegrade Use of Intra-Aortic Balloon Pump as Bridge to Transplantation

Progress in linking the farad and the R/sub K/ value to the SI units at BNM-LCIE

Fundamentals of aerosol therapy in critical care

Quantum wave packets on Kepler elliptic orbits.

Inhaled antimicrobial prescribing for Pseudomonas aeruginosa infections in Europe

Polymerized cyclodextrin microparticles for sustained antibiotic delivery in lung infections